⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXEO News
Lexeo Therapeutics, Inc. Common Stock
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
prnewswire.com
GTBP
LXEO
ANIX
TEM
CTOR
GTBP
LXEO
ANIX
TEM
CTOR
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
globenewswire.com
LXEO